Portfolio Company · Operating Co.

Centrient Pharmaceuticals

Healthcare

backed byBain Capital

CurrentHealthcare

a portfolio company of

Bain Capital

Status on record: Current

PE Firm Index

Who owns Centrient Pharmaceuticals?

Centrient Pharmaceuticals is listed as a current portfolio company of Bain Capital on Bain Capital's own portfolio page.

Company Snapshot

Centrient Pharmaceuticals is a Healthcare company. Its owner on record, Bain Capital, is a private equity firm founded in 1984, headquartered in Boston, United States, with $185 billion under management. Bain Capital lists 133 companies in the index, 26 of them in Healthcare.

SectorHealthcare

Parent PE firmBain Capital

Ownership statusCurrent

WebsiteNot on record

About the owner

Bain Capital

Headquarters: Boston, United States
Founded: 1984
AUM: $185 billion
Strategy: Private Equity, Venture Capital, Leveraged Buyouts, Growth Capital, Credit, Impact Investing, Special Situations, Real Estate
Sectors: Retail, Healthcare, Technology
Companies in the index: 133

Bain Capital, LP is a prominent American private investment firm that specializes in a wide array of alternative asset classes including private equity, venture capital, and credit.

Read the Bain Capital profile

Questions about Centrient Pharmaceuticals

Who owns Centrient Pharmaceuticals?

Centrient Pharmaceuticals is listed as a current portfolio company of Bain Capital on Bain Capital's own portfolio page.

What sector is Centrient Pharmaceuticals in?

Centrient Pharmaceuticals is in Healthcare. Classified from the owner's portfolio label.

Where is Bain Capital headquartered?

Bain Capital is headquartered in Boston, United States.

What else does Bain Capital own in Healthcare?

Bain Capital lists 25 other Healthcare companies in the index, including Asia Pacific Medical Group, athenahealth, Aveanna Healthcare, Avistone and Beeline Medicines Corporation.

Sources

Bain Capital
https://baincapitalprivateequity.com/portfolio

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Centrient Pharmaceuticals and does not provide investment advice.

Other portfolio companies of Bain Capital

6 of 132 shown

1440 Foods

Consumer

360 ONE

Financial & Business Services

A Cloud Guru

Advantage Solutions (FKA Daymon Worldwide)

Financial & Business Services

Ahlstrom Munksjö

Industrials

American Trailer Works

Industrials

See the full Bain Capital portfolio.

Other Healthcare companies held by Bain Capital

Asia Pacific Medical Group athenahealth Aveanna Healthcare Avistone

Beeline Medicines Corporation Cardurion

Other Healthcare portfolio companies

via Wavemaker 360 Health

3P Biopharmaceuticals

via Marlin Equity Partners

Browse PE-backed companies.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

Bain Capital

Boston, United States

Status: Current

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.